Published in Biosemiotics on March 28, 2017
ON THE TOPOGRAPHY OF THE GENETIC FINE STRUCTURE. Proc Natl Acad Sci U S A (1961) 9.42
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell (2015) 7.80
Biotechnology. Regulating gene drives. Science (2014) 4.25
Pitfalls of genetic testing. N Engl J Med (1996) 3.01
Error thresholds of replication in finite populations mutation frequencies and the onset of Muller's ratchet. J Theor Biol (1989) 1.76
Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J Biochem Mol Biol (2004) 1.64
The CRISPR craze. Science (2013) 1.63
Evidence of non-random mutation rates suggests an evolutionary risk management strategy. Nature (2012) 1.56
Stress-directed adaptive mutations and evolution. Mol Microbiol (2004) 1.35
A biochemical mechanism for nonrandom mutations and evolution. J Bacteriol (2000) 1.17
Proteomics as a complementary tool for identifying unintended side effects occurring in transgenic maize seeds as a result of genetic modifications. J Proteome Res (2008) 1.05
Molecular profiling--a tool for addressing emerging gaps in the comparative risk assessment of GMOs. Environ Int (2011) 0.92
Making sense of chromatin states. Nat Methods (2011) 0.85
Comprehending the Semiosis of Evolution. Biosemiotics (2016) 0.82
The Semiosis of "Side Effects" in Genetic Interventions. Biosemiotics (2016) 0.79
Do we have a moral obligation to synthesize organisms to increase biodiversity? On kinship, awe, and the value of life's diversity. Bioethics (2013) 0.79
Evolutionary biosemiotics and multilevel construction networks. Biosemiotics (2016) 0.78
Germ-line enhancement of humans and non-humans. Kennedy Inst Ethics J (2005) 0.78